Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PNTG · against 588 other Healthcare companies listed in US-listed
Ranked #173 of 589 · scores higher than 70% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including PNTG · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PNTG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.2% | -4.3% | 73% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 3.7% | -0.8% | 64% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 2.4% | -2.3% | 67% | 20% | |
| Book yieldHigher is better · 587 reported | 24.9% | 25.9% | 49% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 163 | 1.6B USD | 53 | 48 | |
| 163 | 258.2B USD | 53 | 47 | |
| 173 | 457M USD | 52 | 58 | |
| 173 | 10.0B USD | 52 | 43 | |
| 173 | 1.4B USD | 52 | 53 | |
| 173 | 374M USD | 52 | 66 | |
| 173 | 21.7B USD | 52 | 32 | |
| 178 | 34.6B USD | 51 | 58 | |
| 178 | 18.5B USD | 51 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score